Stock ScreenerStock IdeasTop Stocks To Sell NowStocks to Sell Today: Zen Rating of F As Of Wednesday, July 2, 2025F rated (Strong Sell) stocks have averaged an -8.02% annual decline going back to 2003. Even worse is how bad they do during corrections and bear markets. Own them at your own risk.
Stock ScreenerStock IdeasTop Stocks To Sell Now
Market Cap: $30M - $200B
Zen Rating: F
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DXLG | DESTINATION XL GROUP INC | NASDAQ | Apparel Retail | F | $59.73M | $1.11 | -1.77% | $9.30M | -18.50x | 1.70 | United States | |
| ANRO | ALTO NEUROSCIENCE INC | NYSE | Biotechnology | F | $59.56M | $2.20 | -4.76% | -$60.53M | -0.94x | 0.24 | United States | |
| HYPR | HYPERFINE INC | NASDAQ | Medical Devices | F | $56.04M | $0.72 | -2.96% | -$39.32M | -1.33x | 0.24 | United States | |
| GRWG | GROWGENERATION CORP | NASDAQ | Specialty Retail | F | $55.63M | $0.94 | 7.47% | -$30.60M | -1.11x | 0.48 | United States | |
| DMYY | DMY SQUARED TECHNOLOGY GROUP INC | NYSEMKT | Shell Companies | F | $50.94M | $13.00 | -1.14% | -$4.79M | -9.85x | -1.04 | United States | |
| HOWL | WEREWOLF THERAPEUTICS INC | NASDAQ | Biotechnology | F | $48.91M | $1.09 | 6.86% | -$65.02M | -0.66x | 0.87 | United States | |
| CBUS | CIBUS INC | NASDAQ | Biotechnology | F | $47.45M | $1.38 | -2.13% | -$233.89M | -0.13x | 3.72 | United States | |
| DTIL | PRECISION BIOSCIENCES INC | NASDAQ | Biotechnology | F | $46.57M | $4.20 | -2.33% | -$16.57M | -1.63x | 1.52 | United States | |
| WBUY | WEBUY GLOBAL LTD | NASDAQ | Internet Retail | F | $46.55M | $7.73 | 37.30% | -$4.29M | -6.44x | 2.28 | Cayman Islands | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | NASDAQ | Biotechnology | F | $44.92M | $2.15 | -7.33% | -$128.80M | -0.29x | 4.21 | United States | |
| MODV | MODIVCARE INC | NASDAQ | Medical Care Facilities | F | $44.78M | $3.12 | -8.50% | $1.20M | -0.19x | -20.14 | United States | |
| ATNM | ACTINIUM PHARMACEUTICALS INC | NYSEMKT | Biotechnology | F | $43.67M | $1.40 | -1.41% | -$44.71M | -0.95x | 1.67 | United States | |
| TLYS | TILLY's INC | NYSE | Apparel Retail | F | $41.61M | $1.38 | 10.40% | -$36.17M | -0.85x | 3.22 | United States | |
| INDO | INDONESIA ENERGY CORP LTD | NYSEMKT | Oil & Gas E&P | F | $41.45M | $2.98 | -4.49% | -$4.81M | -5.42x | 0.21 | Indonesia | |
| AGFY | AGRIFY CORP | NASDAQ | Engineering & Construction | F | $41.33M | $21.18 | 0.42% | -$46.26M | -0.48x | 0.70 | United States | |
| KPTI | KARYOPHARM THERAPEUTICS INC | NASDAQ | Biotechnology | F | $37.24M | $4.31 | -1.82% | -$19.64M | -0.53x | -1.62 | United States | |
| TELO | TELOMIR PHARMACEUTICALS INC | NASDAQ | Biotechnology | F | $37.20M | $1.25 | -18.30% | -$12.53M | -2.98x | -4.05 | United States | |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | NASDAQ | Biotechnology | F | $36.79M | $1.51 | 2.72% | -$69.25M | -0.07x | 0.13 | United States | |
| KLTO | KLOTHO NEUROSCIENCES INC | NASDAQ | Biotechnology | F | $36.72M | $1.13 | 56.94% | -$6.80M | -3.14x | 3.68 | United States | |
| AIFF | FIREFLY NEUROSCIENCE INC | NASDAQ | Information Technology Services | F | $36.40M | $2.83 | -3.41% | -$21.19M | -0.84x | 1.38 | United States | |
| PEPG | PEPGEN INC | NASDAQ | Biotechnology | F | $36.32M | $1.11 | -3.48% | -$101.26M | -0.35x | 0.39 | United States | |
| BGFV | BIG 5 SPORTING GOODS CORP | NASDAQ | Specialty Retail | F | $32.45M | $1.42 | 19.33% | $26.24M | -0.40x | 2.95 | United States |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have a premium account? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.